The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(-)-(2S)-1-Benzyl-4-(cyclohexylmethyl)-2-isopropyl-1,4-diazepane ID: ALA4099831
PubChem CID: 137660937
Max Phase: Preclinical
Molecular Formula: C22H36N2
Molecular Weight: 328.54
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)[C@H]1CN(CC2CCCCC2)CCCN1Cc1ccccc1
Standard InChI: InChI=1S/C22H36N2/c1-19(2)22-18-23(16-20-10-5-3-6-11-20)14-9-15-24(22)17-21-12-7-4-8-13-21/h4,7-8,12-13,19-20,22H,3,5-6,9-11,14-18H2,1-2H3/t22-/m1/s1
Standard InChI Key: AGMLFCMKGBGLQJ-JOCHJYFZSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
28.9343 -9.5613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6760 -9.2181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4145 -9.5808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7393 -10.3619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5912 -10.3815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2475 -11.0110 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0697 -11.0168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4209 -11.7608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8870 -11.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0572 -9.0761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8156 -9.3804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9259 -10.1874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6803 -10.4921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3258 -9.9905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2119 -9.1804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4524 -8.8718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0693 -11.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6679 -11.0241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8510 -11.0172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4356 -11.7227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8432 -12.4365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6589 -12.4399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9552 -12.4323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2353 -11.8282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
3 5 1 0
4 6 1 0
5 7 1 0
6 7 1 0
7 8 1 6
6 9 1 0
3 10 1 0
10 11 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
9 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
8 23 1 0
8 24 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 328.54Molecular Weight (Monoisotopic): 328.2878AlogP: 4.80#Rotatable Bonds: 5Polar Surface Area: 6.48Molecular Species: BASEHBA: 2HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.59CX LogP: 5.24CX LogD: 2.21Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.77Np Likeness Score: -0.66
References 1. Fanter L, Müller C, Schepmann D, Bracher F, Wünsch B.. (2017) Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novel σ1 receptor ligands., 25 (17): [PMID:28764962 ] [10.1016/j.bmc.2017.07.027 ]